Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.
Tran Van Hoi E, Santegoets SJ, Mooijaart SP, Van Heemst D, Özkan A, Verdegaal EME, Slingerland M, Kapiteijn E, van der Burg SH, Portielje JEA, Welters MJP, de Glas NA. Tran Van Hoi E, et al. Among authors: slingerland m. Immun Ageing. 2024 Nov 27;21(1):83. doi: 10.1186/s12979-024-00463-y. Immun Ageing. 2024. PMID: 39593063 Free PMC article.
Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A prospective cohort study.
van Holstein Y, Trompet S, van Munster BC, van den Berkmortel PJE, van Heemst D, de Glas NA, Slingerland M, Slagboom PE, Holterhues C, Labots G, Mooijaart SP, Portielje JEA, van den Bos F. van Holstein Y, et al. Among authors: slingerland m. J Geriatr Oncol. 2024 Nov;15(8):102075. doi: 10.1016/j.jgo.2024.102075. Epub 2024 Oct 16. J Geriatr Oncol. 2024. PMID: 39414486 Free article.
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study.
Stroes CI, Meijer SL, Creemers GJ, Hooijer GKJ, Mohammad NH, Los M, Slingerland M, Hospers GAP, Cats A, Beerepoot LV, Bijlsma MF, van Laarhoven HWM. Stroes CI, et al. Among authors: slingerland m. Transl Oncol. 2024 Nov;49:102079. doi: 10.1016/j.tranon.2024.102079. Epub 2024 Aug 15. Transl Oncol. 2024. PMID: 39151279 Free PMC article.
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Baltussen JC, van den Bos F, Slingerland M, Binda TRR, Liefers GJ, van den Hout WB, Fiocco M, Verschoor AJ, Cloos-van Balen M, Holterhues C, Houtsma D, Jochems A, Spierings LEAMM, van Bodegom-Vos L, Mooijaart SP, Gelderblom H, Speetjens FM, de Glas NA, Portielje JEA. Baltussen JC, et al. Among authors: slingerland m. BMJ Open. 2024 Aug 13;14(8):e089882. doi: 10.1136/bmjopen-2024-089882. BMJ Open. 2024. PMID: 39142680 Free PMC article.
Allocation and value of curative oncological treatment in frail and fit older patients with esophageal cancer: An observational cohort study.
van der Poort EKJ, van Holstein Y, Slingerland M, Trompet S, van den Bos F, Portielje JEA, Steyerberg EW, van den Akker-van Marle ME, Bos WJW, Mooijaart SP, van den Hout WB. van der Poort EKJ, et al. Among authors: slingerland m. J Geriatr Oncol. 2024 Sep;15(7):102046. doi: 10.1016/j.jgo.2024.102046. Epub 2024 Aug 12. J Geriatr Oncol. 2024. PMID: 39138114 Free article.
Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastroesophageal Cancer.
van Velzen MJM, Pape M, Sprangers MAG, van Kleef JJ, Mostert B, Beerepoot LV, Slingerland M, Gootjes EC, Hoekstra R, van de Poll-Franse LV, Haj Mohammad N, van Laarhoven HWM. van Velzen MJM, et al. Among authors: slingerland m. J Natl Compr Canc Netw. 2024 Jul 8;22(7):455-461. doi: 10.6004/jnccn.2024.7014. J Natl Compr Canc Netw. 2024. PMID: 38977016
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Kroese TE, Bronzwaer S, van Rossum PSN, Schoppman SF, Deseyne PRAJ, van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds JV, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, van Berge Henegouwen MI, Hulshoff MCCM, van Dieren J, Vollebergh M, van Sandick JW, Jeene P, Muijs C, Slingerland M, Voncken FEM, Hartgrink H, Creemers GJ, van der Sangen MJC, Nieuwenhuijzen GAP, Berbee M, Verheij M, Wijnhoven B, Beerepoot LV, Mohammad NH, Mook S, Ruurda JP, Kolodziejczyk P, Polkowski WP, Wyrwicz L, Alsina M, Tabernero J, Pera M, Kanonnikoff TF, Cervantes A, Nilsson M, Monig S, Wagner AD, Guckenberger M, Griffiths EA, Smyth E, Hanna GB, Markar S, Chaudry MA, Hawkins MA, Cheong E, van Laarhoven HWM, van Hillegersberg R; OMEC collaborators. Kroese TE, et al. Among authors: slingerland m. Eur J Cancer. 2024 Jun;204:114062. doi: 10.1016/j.ejca.2024.114062. Epub 2024 Apr 16. Eur J Cancer. 2024. PMID: 38678762 Free article.
101 results